Pharming Group N.V.

PHAR NASDAQ Santé & Biotech Europe
12.87 $
1.77 %

Entreprise biopharmaceutique développant et commercialisant des traitements basés sur la technologie de protéines recombinantes pour les maladies rares.

Performance & Momentum

6 Months 23.89 %
1 Year 21.05 %
3 Years 5.50 %
5 Years 12.04 %

Similar stocks to Pharming Group N.V.

Anantys Community

Be the first to share your analysis on Pharming Group N.V..

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases